Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/SEPN/vs peers

SEPNSepterna, Inc.vs its industry peers

A metric-by-metric comparison of Septerna, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.

Full peer comparison
Peers: same SEC industry
CompanyMarket capP/E (TTM)P/BP/SRevenue growth (YoY)Earnings growth (YoY)EBIT marginROEROICPiotroski F1y total returnDividend yield
SEPNSepterna, Inc.This$2.0B#8—5.3x#744.4x#84174.5%#131.9%#4-148.6%#8-12.6%#2——118.1%#2—
IMNMImmunome Inc.$2.3B#1—4.4x#5332.7x#10-23.2%#1027.5%#5-3228.8%#10-40.4%#8-72.8%#6—19.4%#6—
XNCRXencor Inc$2.3B#2—4.5x#618.2x#513.7%#760.5%#2-141.4%#7-18.3%#4-31.5%#4—120.4%#1—
VERAVera Therapeutics, Inc.$2.2B#3—5.4x#8——-96.9%#9—-73.5%#11-72.7%#5—18.5%#7—
PVLAPALVELLA THERAPEUTICS, INC.$2.2B#4—10.2x#1051.6x#965.3%#2-139.3%#10-90.2%#6-19.2%#5——99.0%#3—
PRGOPERRIGO Co plc$2.2B#5—0.9x#10.5x#1-2.8%#9-729.7%#13-26.4%#3-56.7%#10-20.9%#34#1-18.0%#97.3%#1
HRMY$2.2B#612.0x#12.2x#42.5x#321.5%#69.1%#824.0%#115.9%#125.5%#14#1——
ZYMEZymeworks Inc.$2.1B#7—26.6x#1220.2x#638.9%#533.9%#3-87.3%#5-100.9%#12——59.5%#4—
TRVITrevi Therapeutics, Inc.$2.0B#9—6.1x#9——10.7%#7—-13.3%#3——29.6%#5—
SRPTSarepta Therapeutics, Inc.$2.0B#10—1.3x#21.1x#24.3%#8-403.3%#12-37.5%#4-46.7%#9-73.0%#7—-24.2%#10—
XERSXeris Biopharma Holdings, Inc.$1.9B#11——6.5x#443.7%#4101.0%#18.5%#2—20.6%#2—4.6%#8—
AGIO$1.9B#12—1.8x#334.5x#748.0%#3-161.3%#11-873.9%#9-40.3%#7————
SLS$1.8B#13—13.0x#11—-100.0%#1113.0%#6—-19.5%#6————

Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-04.

Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice

SEPN's peers

IMNMXNCRVERAPVLAPRGOHRMYZYMETRVISRPTXERSAGIOSLS
← SEPN overview